Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

IBBQvsPBEETF Comparison

ETF 1
IBBQ

Invesco Nasdaq Biotechnology ETF

This fund is part of
US Health Care
-0.7%
VS
ETF 2
PBE

Invesco Dynamic Biotechnology & Genome ETF

This fund is part of
BioTech & Genomics
+3.8%

Invesco Nasdaq Biotechnology ETF (IBBQ) belongs to the US Health Care segment. Invesco Dynamic Biotechnology & Genome ETF (PBE) is part of the BioTech & Genomics segment. IBBQ's top 3 sector exposures are Healthcare and Non-Energy Materials. In contrast, PBE's top sector exposures are Healthcare  IBBQ is less expensive with a Total Expense Ratio (TER) of 0.19%, versus 0.58% for PBE. IBBQ is up 15.4% year-to-date (YTD) with +$3M in YTD flows. PBE performs worse with 12.21% YTD performance, and +$2M in YTD flows. Run a side-by-side ETF comparison of IBBQ and PBE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

IBBQ vs PBE performance and flow charts

Performance

-2.0-1.00.01.02.03.04.0%Jun 30Jul 8Jul 15Jul 22Jul 29

Cumulative Flows

0 M1 M2 M3 M4 M5 MJun 30Jul 8Jul 15Jul 22Jul 29

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/30/2026
1M3MYTD1Y3Y5Y
Perf.
IBBQ
PBE
+0.10%+1.68%
+12.21%+15.70%
+15.40%+12.21%
+46.91%+41.02%
+62.42%+46.86%
+32.40%+23.60%
Flows
IBBQ
PBE
+$4M+$5M
+$3M+$6M
+$3M+$2M
+$23M-$17M
+$39M-$51M
+$11M-$47M
Volatility and drawdown
3M1Y3Y5Y
Volatility
IBBQ
PBE
+22.34%+18.79%
+20.29%+18.94%
+20.25%+20.28%
+21.96%+22.48%
Max drawdown
IBBQ
PBE
-5.97%-4.30%
-8.38%-11.70%
-23.78%-22.21%
-38.09%-34.74%
Max drawdown duration
IBBQ
PBE
23d23d
48d166d
375d324d
1543d1540d
Trading data

Create an account to view trading data

Join for free
IBBQ
PBE
Last sale
7/31/2026 at 1:30 PM
$32.10
$89.61
Previous close
07/30/2026
$32.70
$91.10
Consolidated volume
07/30/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
IBBQ
PBE
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/31/2026 at 1:30 PM
Live
Closed
IBBQ
PBE
Last price
$32.10
$89.61
1D performance
-1.83%
-1.64%
AuM$76.45 M$287.14 M
E/R0.19%0.58%
Characteristics
IBBQ
PBE
Management strategyPassivePassive
ProviderInvescoInvesco
BenchmarkNASDAQ Biotechnology IndexDynamic Biotech & Genome Intellidex Index
N° of holdings25130
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJune 9, 2021June 23, 2005
ESGNoNo
Advertisement
Exposure

Countries

IBBQ
USA
88.1%
Other
11.9%
PBE
USA
97.25%
Other
2.75%

Sectors

IBBQ
Healthcare
99.98%
Other
0.02%
PBE
Healthcare
100%
Other
-0%
Advertisement

Diversification

IBBQ

Total weight of top 15 holdings out of 15

49.38%
PBE

Total weight of top 15 holdings out of 15

60.29%

Top 15 holdings

Data as of June 30, 2026
IBBQ
Vertex Pharmaceuticals, Inc.
8.16%
Amgen, Inc.
7.91%
Gilead Sciences, Inc.
7.07%
Regeneron Pharmaceuticals, Inc.
4.62%
Alnylam Pharmaceuticals, Inc.
2.76%
Revolution Medicines, Inc.
2.74%
Biogen, Inc.
2.26%
Illumina, Inc.
1.89%
Moderna, Inc.
1.89%
Royalty Pharma Plc
1.77%
Roivant Sciences Ltd.
1.74%
argenx SE
1.73%
United Therapeutics Corp.
1.63%
Incyte Corp.
1.61%
Insmed, Inc.
1.59%
PBE
Vertex Pharmaceuticals, Inc.
5.12%
Biogen, Inc.
5.08%
Amgen, Inc.
4.84%
Royalty Pharma Plc
4.74%
Regeneron Pharmaceuticals, Inc.
4.53%
Alnylam Pharmaceuticals, Inc.
4.48%
Gilead Sciences, Inc.
4.34%
United Therapeutics Corp.
4.26%
Bio-Techne Corp.
3.67%
Veracyte, Inc.
3.39%
CareDx, Inc.
3.31%
Vericel Corp.
3.27%
Repligen Corp.
3.16%
PTC Therapeutics, Inc.
3.09%
Protagonist Therapeutics, Inc.
3.02%
Frequently asked questions about IBBQ and PBE

How have the IBBQ and PBE ETFs performed in 2026?

As of July 30, 2026, IBBQ is up 15.4% year-to-date (YTD), while PBE has returned 12.21%. That puts IBBQ better performer ahead so far this year.

Which ETF is attracting more investor money: IBBQ or PBE?

Year-to-date, the IBBQ ETF saw +$3M in flows, compared to +$2M for PBE.

Which ETF is more volatile: IBBQ or PBE?

Over the past year, IBBQ had a volatility of 20.29%, while PBE experienced 18.94%.

Which ETF is bigger: IBBQ or PBE?

As of July 30, 2026, IBBQ holds $76.45 M in assets under management (AUM), while PBE manages $287.14 M.

What sectors do the IBBQ and PBE ETFs invest in?

IBBQ leans toward sectors like Healthcare. Meanwhile, PBE focuses on Healthcare.

What are the top holdings of the IBBQ ETF and PBE ETF?

IBBQ top holdings include Vertex Pharmaceuticals, Inc., Amgen, Inc. and Gilead Sciences, Inc.. PBE holds in its top three: Vertex Pharmaceuticals, Inc., Biogen, Inc. and Amgen, Inc..

Which ETF is more diversified: IBBQ or PBE?

IBBQ holds 251 securities with 49.38% of its assets in the top 15. PBE has 30 securities and a top 15 weight of 60.29%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder